Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi's $1.1B eczema drug hits midphase goal, spurring talk of phase 3 and new indications
Fierce Biotech
Tue, 06/27/23 - 10:09 am
Tags:
Sanofi, clinical trials, eczema, Kymab, amlitelimab
5 FDA decisions to watch in the third quarter
BioPharma Dive
Mon, 06/26/23 - 10:04 am
Tags:
FDA, SAGE Therapeutics, Biogen, zuranolone, Eisai, Leqembi, Sanofi, AstraZeneca, nirsevimab, Iveric Bio, Zimura, Alnylam, Onpattro
Alphabet's quantum spinoff starts working with AstraZeneca, Sanofi to accelerate R&D
Fierce Biotech
Fri, 06/23/23 - 10:01 am
Tags:
Alphabet, SandboxAQ, AstraZeneca, Sanofi, R&D, funding, molecular simulation, artificial intelligence
Aslan sells Japanese rights to would-be Dupixent rival for $12M
Fierce Biotech
Thu, 06/22/23 - 10:41 pm
Tags:
Aslan, Dupixent, Japan, eczema, Sanofi, Regeneron, eblasakimab
Sanofi says arbitration court rejects Boehringer's Zantac claims
Reuters
Wed, 06/21/23 - 10:53 am
Tags:
Sanofi, Boehringer Ingelheim, Zantac, legal
4 ways Sanofi is using AI to power pharma innovations
Beckers Hospital Review
Tue, 06/13/23 - 10:59 pm
Tags:
Sanofi, artificial intelligence, innovation
Biotech M&A is picking back up - here are the latest deals
BioPharma Dive
Tue, 06/13/23 - 11:37 am
Tags:
Novartis, Chinook Therapeutics, Paratek, Sobi, CTI BioPharma, Astellas, Iveric Bio, Assertio Holdings, Spectrum Pharmaceuticals, Merck, Prometheus Biosciences, Pfizer, Seagen, Sanofi, Provention Bio, Sun Pharma, Concert Pharmaceuticals, BioNTech, InstaDeep, AstraXeneca, CinCor Pharma, Ipsen, Albireo, Chiesi, Amryt, Moderna Therapeutics, OriCiro Genomics
Medicare sets next tranche of drugs to face price hike penalties
BioPharma Dive
Sun, 06/11/23 - 11:02 pm
Tags:
Medicare, Inflation Reduction Act, drug pricing, Amgen, Sanofi, Seagen
FDA sets the stage for adcomm on Sanofi, AZ's RSV prospect later this week
Fierce Pharma
Wed, 06/7/23 - 09:42 pm
Tags:
Sanofi, AstraZeneca, GSK, Pfizer, RSV, vaccines, FDA
Dupixent reclaims throne as top Rx, OTC pharma brand in May
Medical Marketing and Media
Tue, 06/6/23 - 11:13 am
Tags:
Dupixent, Sanofi, Regeneron, DTC advertising
Sanofi sees midphase success in multiple sclerosis decades after safety concerns scuttled peers
Fierce Biotech
Wed, 05/31/23 - 10:54 am
Tags:
Sanofi, MS, multiple sclerosis, clinical trials, frexalimab
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
Tags:
FDA, Albireo Pharma, Aldeyra Therapeutics, Alvotech, Amneal Pharmaceuticals, Argenx, ARS Pharmaceuticals, AstraZeneca, Bayer, Bio-Thera Solutions, Biogen, BioMarin Pharmaceutical, Bristol Myers Squibb, Eisai, Eton Pharmaceuticals, F2G, Fabre-Kramer Pharmaceuticals, Fresenius, GSK, Intercept Pharmaceuticals, Ipsen, Ironwood Pharmaceuticals, Merck, Novaliq, Pfizer, Regeneron, Roche, Sanofi, Sarepta Therapeutics, Shionogi, Swedish Orphan Biovitrum, Takeda, Teva Pharmaceutica, UCB Pharma
Sanofi, Regeneron flesh out COPD data with Dupixent
Pharmaphorum
Mon, 05/22/23 - 10:16 am
Tags:
Sanofi, Regeneron, COPD, Dupixent
Supreme Court rules against Amgen bid to revive cholesterol drug patents
KFGO/Reuters
Thu, 05/18/23 - 11:24 am
Tags:
Supreme Court, Amgen, Sanofi, Regeneron, patents, Repatha, legal
2023’s biggest launches: the story so far
EP Vantage
Fri, 05/12/23 - 10:19 am
Tags:
drug launches, AbbVie, Almirall, Apellis Pharmaceuticals, Astellas, AstraZeneca, Biogen, CRISPR Therapeutics, Daiichi Sankyo, Eli Lilly, Genmab, GSK, Iveric Bio, Pfizer, Roche, SAGE Therapeutics, Sanofi, Sarepta Therapeutics, Shionogi, Swedish Orphan Biovitrum, Vertex Pharmaceuticals
Sanofi, AstraZeneca Report Promising RSV Pediatric Data Ahead of Pfizer Adcomm
BioSpace
Fri, 05/12/23 - 10:16 am
Tags:
Sanofi, AstraZeneca, RSV, antibodies, infants, clinical trials
What you need to know about pharma, PBM execs testifying on insulin prices
Medical Marketing and Media
Wed, 05/10/23 - 11:15 pm
Tags:
PBMs, insulin, diabetes, drug pricing, Sanofi, Novo Nordisk, Eli Lilly
A blockbuster year could be building
EP Vantage
Wed, 05/10/23 - 09:55 am
Tags:
AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Daiichi Sankyo, Eli Lilly, Gilead Sciences, Horizon Therapeutics, Merck, Moderna Therapeutics, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi
Biogen, Novartis, Sanofi Cull Candidates in Q1 Pipeline Reprioritizations
BioSpace
Fri, 05/5/23 - 12:09 pm
Tags:
Biogen, Novartis, Sanofi, earnings, R&D
Chronic hives: Four major clinical trials to watch in 2023
Clinical Trials Arena
Wed, 05/3/23 - 11:53 am
Tags:
chronic hives, chronic urticaria, clinical trials, Sanofi, Regeneron, dupilumab, Amgen, tezepelumab, Allakos, lirentelimab, Celldex Therapeutics, barzolvolimab

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.